SCHEMBL21730778

SCHEMBL21730778

O=C1COC2CCN(C(=O)N3CCC(Oc4ccc(C(F)(F)F)cc4)CC3)C[C@H]2N1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 10/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21722872 1.00 MGLL (0.61) MGLL
SCHEMBL23149037 1.00 MGLL (0.61) MGLL
SCHEMBL21730887 0.94 MGLL (0.63) MGLL
SCHEMBL23853048 0.89 MGLL (0.56) MGLL
SCHEMBL21723095 0.89 MGLL (0.60) MGLL
SCHEMBL29616491 0.89 MGLL (0.60) MGLL
SCHEMBL21730909 0.87 MGLL (0.58) MGLL
SCHEMBL24095491 0.87 MGLL (0.56) MGLL
SCHEMBL25784975 0.87 MGLL (0.56) MGLL
SCHEMBL24095474 0.86 MGLL (0.59) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3837263-B1 NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS HOFFMANN LA ROCHE (CH) 2024-07-03 — — EP disclosed
WO-2020035424-A1 NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2020-02-20 — — WO disclosed
WO-2020035425-A1 NEW HETEROCYCLIC COMPOUNDS AS MONOACYLGLYCEROL LIPASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2020-02-20 — — WO disclosed
Send feedback